-First Post If we are willing to believe the best practice examples of cash transfers from Brazil and Philippines, and trust the UPA on the fact that their cash-for-subsidy is going to be all hunky-dory, we also have a right to believe Sitaram Yechury’s concerns about the fancy plan. According to the CPM leader, the cash transfer is a ploy by the government to dismantle the PDS and systematically reduce subsidies. “This is...

-The Business Standard UID can shift focus from the government's functioning to the intended beneficiaries and ease of access The central government is seriously thinking of putting in place a technology-based platform to hand over subsidies directly into the hands of their intended beneficiaries. A number of pilots are under way for handing over, for example, kerosene subsidies for household consumption. While this is largely a central government initiative, state governments...

-The Wall Street Journal   While modern crop engineering faces endless red tape, more slipshod cross-breeding gets a free pass. India has enjoyed signal successes with genetic engineering in agriculture. But today the nation's relationship with this critical biotechnology is in total disarray, the victim of activists' scaremongering and government pandering. Delhi should know better. Following the adoption of the genetically improved varieties and intensive crop management practices of the Green Revolution, from 1960...

-The Indian Express Cash transfers seem to be the latest fad. With elections looming, the Prime Minister’s National Committee on Direct Cash Transfers has been tasked with an ambitious mandate to provide vision and direction to enable direct cash transfers of subsidies under various government schemes and programmes to individuals to enhance efficiency. Certain activists warn against an ill-considered and hasty transition from food to cash. Others believe directly transferring the...

-The Times of India A once-a-week medicine for diabetics — a disease that affects nearly 63 million Indians — could soon become a reality. Studies on diabetes have seen a global upsurge, with the latest data showing that bio-pharmaceutical research companies across the globe are busy developing 221 innovative new medicines. The drugs, which will help around 347 million patients include new therapies that target key abnormalities of pancreatic cells, increase insulin secretion...